Merck KGaA (MKGAF)
164.00
+0.55
(+0.34%)
USD |
OTCM |
Aug 25, 16:00
Merck EPS Diluted (Quarterly) : 1.310 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.310 |
| March 31, 2026 | 1.773 |
| December 31, 2025 | 0.854 |
| September 30, 2025 | 2.424 |
| June 30, 2025 | 1.700 |
| March 31, 2025 | 1.779 |
| December 31, 2024 | 1.636 |
| September 30, 2024 | 2.044 |
| June 30, 2024 | 1.503 |
| March 31, 2024 | 1.732 |
| December 31, 2023 | 1.450 |
| September 30, 2023 | 1.849 |
| June 30, 2023 | 1.762 |
| March 31, 2023 | 1.964 |
| December 31, 2022 | 1.536 |
| September 30, 2022 | 2.137 |
| June 30, 2022 | 2.122 |
| March 31, 2022 | 2.271 |
| December 31, 2021 | 2.108 |
| September 30, 2021 | 2.063 |
| June 30, 2021 | 2.066 |
| March 31, 2021 | 2.070 |
| December 31, 2020 | 1.196 |
| September 30, 2020 | 2.164 |
| June 30, 2020 | 0.7346 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.155 |
| December 31, 2019 | 0.8098 |
| September 30, 2019 | 0.8771 |
| June 30, 2019 | 1.217 |
| March 31, 2019 | 0.4936 |
| December 31, 2018 | 0.5293 |
| September 30, 2018 | 0.9096 |
| June 30, 2018 | 0.6788 |
| March 31, 2018 | 0.9639 |
| December 31, 2017 | 2.743 |
| September 30, 2017 | 1.738 |
| June 30, 2017 | 1.078 |
| March 31, 2017 | 1.279 |
| December 31, 2016 | 0.6681 |
| September 30, 2016 | 1.172 |
| June 30, 2016 | 0.813 |
| March 31, 2016 | 1.499 |
| December 31, 2015 | 0.3174 |
| September 30, 2015 | 0.9337 |
| June 30, 2015 | 0.8739 |
| March 31, 2015 | 0.7307 |
| December 31, 2014 | 0.7995 |
| September 30, 2014 | 0.7555 |
| June 30, 2014 | 0.96 |
| March 31, 2014 | 0.5138 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| STRATEC SE | 0.3981 |
| Sartorius AG | 0.2219 |
| Petros Pharmaceuticals, Inc. | -0.3038 |
| Danaher Corp. | 1.230 |
| Illumina, Inc. | 1.353 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 574.38M |
| Revenue (Quarterly) | 6.318B |
| Total Expenses (Quarterly) | 5.748B |
| Enterprise Value | 83.26B |
| Gross Profit Margin (Quarterly) | 58.26% |
| Profit Margin (Quarterly) | 9.09% |
| Earnings Yield | 3.88% |
| Operating Earnings Yield | 6.80% |
| Normalized Earnings Yield | 4.574 |